BULLISHWHALES
BullishWhales · Analysts · Analyst Profile

Glen Santangelo

Jefferies · Equity Research Analyst

Analyst rating accuracy & track record

Glen Santangelo does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
ANIPANI Pharmaceuticals Inc
Buy$80.00Mar 2025+7.5%Hit
VTRSViatris Inc
Buy$13.00Mar 2025+50.4%Hit
XERSXeris Pharmaceuticals Inc
Buy$6.00Jan 2025+91.6%Hit
PCRXPacira BioSciences, Inc.
Buy$18.00Sep 2024+96.3%Hit
VTRSViatris Inc
Buy$15.00Jul 2024−9.8%Miss
COLLCollegium Pharmaceutical Inc
Buy$44.00Jun 2024−1.4%Miss
ZTSZoetis Inc
Buy$230.00Dec 2023−18.0%Miss
VRCAVerrica Pharmaceuticals Inc
Buy$10.00Dec 2023−92.4%Hit
AMPHAmphastar P
Buy$70.00Jul 2023−45.1%Miss
COLLCollegium Pharmaceutical Inc
Buy$30.00May 2023+63.8%Hit
VTRSViatris Inc
Buy$15.00Jan 2023−3.9%Miss
PCRXPacira BioSciences, Inc.
Buy$66.00Oct 2022−46.1%Miss
TEVATeva Pharma Industries Ltd ADR
Buy$10.00Oct 2022−3.4%Hit
XERSXeris Pharmaceuticals Inc
Buy$4.00Oct 2022+14.7%Miss
AMPHAmphastar P
Buy$36.00Oct 2022+44.5%Hit
Go to

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.

v1.0.30